Atlas Trials

Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin

Clinical trial NCT01012336 · COMPLETED

Trial details

NCT number
NCT01012336
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy-Induced Nausea and VomitingOvarian Cancer
Start date
2010-05-01
Primary completion
2011-10-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.